Worth Peripherals Ltd (WORTHPERI)

Capital Goods · Packaging · NSE · Updated 1 September 2026

By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings

₹151.3

🎯 Key Takeaways

Worth Peripherals Ltd is transitioning from a mature capital goods packaging business into a multi-business entity with strategic expansion into wellness manufacturing via its subsidiary. The company is executing a capital restructuring plan involving debt-to-equity conversions and subsidiary commercialization, signaling a growth phase with operational diversification rather than organic revenue expansion.
Revenue grew 7.7% QoQ to ₹82 in Q1FY27.
⚠️ 1) Subsidiary contributes zero revenue despite operational commencement, raising questions about commercial viability and timeline to revenue generati

Market Cap

₹238

P/E Ratio

15.5

P/B Ratio

1.37

ROE

11.2%

ROCE

15.9%

Debt/Equity

0.11

Div Yield

0.66%

Promoter

68.2%

✨ Ask AI About WORTHPERI 📊 Interactive Charts

📖 The Story

Worth Peripherals Ltd is transitioning from a mature capital goods packaging business into a multi-business entity with strategic expansion into wellness manufacturing via its subsidiary. The company is executing a capital restructuring plan involving debt-to-equity conversions and subsidiary commercialization, signaling a growth phase with operational diversification rather than organic revenue expansion.

📰 What's Happening

In Q1 FY2026, the company approved the conversion of a ₹30 crore inter-corporate loan into 6 million equity shares at ₹50/share to acquire its subsidiary Worth Wellness Private Limited, alongside finalizing a ₹20 crore loan agreement with the subsidiary. Management confirmed commercial production commenced at the Indore facility on August 1, 2026, and appointed a secretarial auditor for five years. The board also approved related party transaction frameworks and equity share acquisitions. These actions reflect a deliberate capital reallocation strategy to consolidate control over the subsidiary without fresh capital infusion.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	77	75	76	82
Operating Profit	7	7	7	8
OPM %	9.0%	8.7%	9.6%	9.8%
Net Profit	6	4	5	5
EPS	₹2.90	₹2.02	₹2.19	₹2.65

Revenue has plateaued over the past four quarters, hovering between ₹75–82 crores with stable operating margins (~9%), while profitability trends show incremental improvement — PAT rose to ₹553.11 crores in Q1 FY2026 from ₹525.57 lakhs in prior filings (contextualized as ₹5 crores in quarterly data), driven by subsidiary operations. However, the subsidiary currently contributes zero revenue, indicating that profit growth is not yet revenue-led but likely reflects accounting recognition or consolidation effects. EPS increased to ₹2.65 in Q1 FY2026 from ₹2.19 in Q4 FY26, suggesting modest leverage in profitability despite flat top-line growth.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance on revenue or margin targets, but the focus is clearly on operationalizing the subsidiary and restructuring debt via equity conversion. The August 4, 2026, deadline for loan agreement completion and the September 16 AGM for dividend declaration suggest near-term milestones. Management emphasizes audit validation and procedural compliance, with no commentary on future organic growth or market expansion beyond subsidiary integration.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

Item	Mar 2025	Mar 2025	Mar 2026	Mar 2026
Equity Capital	16	16	16	16
Reserves	149	158	166	172
Borrowings	6	19	19	42
Total Liabilities	210	230	237	278
Fixed Assets	87	84	83	80
Investments	0	0	0	0
Total Assets	210	230	237	278

The balance sheet shows minimal equity (₹16 crores) and reserves growing slowly from ₹158 to ₹172 crores, while borrowings remain low and stable at ₹19–42 crores. Total assets have modestly expanded, indicating asset-light operations. The company is not aggressively investing but is carefully managing leverage, with debt-to-equity at 0.11. The loan-to-equity conversion preserves equity base while altering capital structure, suggesting a defensive posture toward capital efficiency rather than expansion.

💰 Cash Flow Statement (₹ Cr)

Item	Mar 2025
Operating	+21
Investing	-26
Financing	+7
Net Cash Flow	+2

👥 Shareholding Pattern

Category	Q2FY26	Q3FY26	Q4FY26	Q1FY27
Promoters	68.2%	68.2%	68.2%	68.2%
FII	0.0%	0.0%	0.0%	0.0%
DII	0.0%	0.0%	0.0%	0.0%
Public	21.9%	21.9%	21.9%	21.9%
# Shareholders	6,777	6,491	6,252	6,060

Promoter holding remains stable at ~68.16% over the last four quarters, with no FII or DII allocations reported. Public shareholding has slightly increased, and the shareholder base has grown to 6,060 investors. Recent insider purchases by promoter group members (Jayvir and Ganiv Chadha) on August 17, 2026, signal confidence but are immaterial in scale. There are no signs of institutional accumulation or exit activity, reflecting limited market interest or passive investment posture.

⚖️ Peer Comparison — Packaging

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
INOXINDIA	19,412	76.2	29.2%	22.8%	0.06
GRWRHITECH	16,598	42.8	22.0%	16.4%	0.00
EPL	8,382	21.6	17.1%	13.8%	0.25
AGI	5,042	13.9	19.6%	17.3%	0.26
UFLEX	4,685	6.9	8.8%	8.4%	1.21
POLYPLEX	3,707	23.9	7.7%	7.2%	0.23
TCPLPACK	3,548	30.7	17.8%	16.1%	0.80
XPROINDIA	2,692	81.5	5.2%	4.3%	0.38
COSMOFIRST	2,446	14.5	11.4%	10.3%	0.98
MOLDTKPAC	2,357	32.2	19.9%	14.5%	0.10

🔗 Peer Stock Analyses

INOXINDIA GRWRHITECH EPL AGI UFLEX

⚠️ Risk Factors

1) Subsidiary contributes zero revenue despite operational commencement, raising questions about commercial viability and timeline to revenue generation. 2) Profitability improvements may be accounting-driven or consolidation-based rather than sustainable, especially with flat revenue trends. 3) High promoter concentration (68%) increases governance and control risk, especially if operational execution falters. 4) Lack of forward guidance or market-specific growth narrative introduces uncertainty around long-term value creation.

📋 Recent Filings

🧠 Analyst's Read

Worth Peripherals is in a strategic pivot phase, using financial engineering and subsidiary integration to reposition its growth trajectory. Investors should monitor revenue contribution from the wellness subsidiary in upcoming quarters, clarity on capital allocation, and whether profitability trends translate into scalable earnings. The absence of institutional interest and limited market visibility warrant caution, even as operational milestones are being hit.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on WORTHPERI

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-09-01.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when WORTHPERI files new disclosures

Track WORTHPERI filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track WORTHPERI — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd